Skip to main content

Advertisement

Table 1 Clinical details of the 10 patients studied

From: Identification of bacteria on the surface of clinically infected and non-infected prosthetic hip joints removed during revision arthroplasties by 16S rRNA gene sequencing and by microbiological culture

Patient no. Sex Age CRP (mg/l) ESR (mm/h) Hb (g/l) WCC (× 109 g/l) Clinical diagnosis Bacteriology results Duration prosthesis in place (months)
1 M 73 < 5 10 117 6.1 Aseptic loosening No growth 178
2 M 69 < 3 ND 150 6.5 Aseptic loosening No growth 48
3 M 61 61 49 130 10.6 Infected Coagulase-negative Staphylococcus (CF, AM, FM) 5
4 F 56 36 ND 134 6.9 Aseptic loosening No growth 79
5 M 65 36 14 142 6.7 Infected No growth 55
6 F 66 < 10 14 148 7.7 Infected Coagulase-negative Staphylococcus (CF, AM, FM) n.d.
7 F 49 45 60 120 8.8 Infected Proteus mirabilis (AM, FM) n.d.
8 M 59 80 30 169 4.2 Aseptic loosening No growth 120
9 M 62 ND ND 119 3.9 Aseptic loosening No growth n.d.
10 M 57 131 ND 106 10.7 Infected No growth n.d.
  1. CRP, C-reactive protein (reference range 0 to 6 mg/l); ESR, erythrocyte sedimentation rate (reference range 1 to 13 mm/h (male), 1 to 20 mm/h (female)); Hb, haemoglobin (reference range 130 to 170 g/l (male), 120 to 150 g/l (female)); WCC, white cell count (reference range 4.0 to 10.0 ng/l); AM, acetabular membrane; CF, capsular fluid; n.d., not determined; FM, femoral membrane.